Last checked at 23 Apr 2018 12:22
23 April 2018
Assura plc
("the Company")
Notifications of transactions by Persons Discharging Managerial Responsibilities ("PDMRs")
The Company has been notified that in respect of the interim dividend paid on 18 April 2018, the following PDMR acquired ordinary shares of 10 pence each in the Company through their participation in the Company's Scrip Dividend Alternative:
PDMR | Date Acquired | Number of shares acquired | Purchase price per Share |
Ed Smith | 18 April 2018 | 956 | £0.6008 |
The Notification of Dealing Form for Mr Smith can be found below.
This notification is made in accordance with the Market Abuse Regulation.
-ENDS-
Notification of dealing form
1 | Details of the person discharging managerial responsibilities/person closely associated
| |||||||
a) | Name
| Ed Smith | ||||||
2 | Reason for the notification
| |||||||
a) | Position/status
| Non-executive Director | ||||||
b) | Initial notification/ Amendment
| Initial notification | ||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||||
a) | Name
| Assura plc | ||||||
b) | LEI
| 21380026T19N2Y52XF72 | ||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 10 pence each
GB00BVGBWW93 | ||||||
b) | Nature of the transaction
| Purchase of shares under the Scrip Dividend Alternative
| ||||||
c) | Price(s) and volume(s)
|
| ||||||
d) | Aggregated information
- Aggregated volume
- Price
|
| ||||||
e) | Date of the transaction
| 18 April 2018 | ||||||
f) | Place of the transaction
| XLON | ||||||
For more information, please contact:
Assura plc |
Tel: 01925 420660 |
Orla Ball | |
Edelman |
Tel: 0203 047 2546 |
John Kiely Mav Wynn Rob Yates |
|
Notes to Editors
Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 30 September 2017, Assura's property portfolio was valued at £1,560 million.
Further information is available at www.assuraplc.com
*EPRA is a registered trademark of the European Public Real Estate Association